Intelgenx Technologies Corp. (QX) Stock Price - IGXT

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Intelgenx Technologies Corp. (QX) IGXT OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0101 1.58% 0.6501 0.66 0.65 0.65 0.64 12:42:56
Bid Price Ask Price Spread Spread % News
0.64 0.66 0.02 3.03% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
27 45,185 $ 0.651101 $ 29,420 90,722 0.3901 - 0.95005
Last Trade Time Type Quantity Stock Price Currency
12:42:56 4,000 $ 0.6501 USD

Intelgenx Technologies Corp. (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 60.79M 93.53M $ -10.11M - - 82.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
18.81k $ - 0.00% - -

more financials information »

Intelgenx Technologies Corp. (QX) News

Loading Messages....

Latest IGXT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IGXT Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.6920.6990.614050.6452103k-0.0419-6.05%
1 Month0.47990.70.45150.6216140k0.170235.47%
3 Months0.50.70.39010.534596k0.150130.02%
6 Months0.51170.70.39010.530081k0.138427.05%
1 Year0.950050.950050.39010.6072241k-0.29995-31.57%
3 Years0.72011.830.39010.8729182k-0.07-9.72%
5 Years0.40021.830.330.7920167k0.249962.44%

Intelgenx Technologies Corp. (QX) Description

IntelGenx is a leading drug delivery company focused on the development of innovative products based on its proprietary oral drug delivery technologies. Established in 2003, the Montreal-based company develops innovative oral drug delivery solutions based on its proprietary platform technologies, VersaFilmTM, VersaTabTM and AdVersaTM. IntelGenx has developed a broad and diverse product portfolio addressing unmet market needs and offering lifecycle management opportunities. Forfivo XLTM, launched in 2012, is the first and only FDA approved once-daily bupropion HCl 450mg dose in a single tablet for the treatment of major depressive disorder. IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, clinical monitoring, IP protection, analytical method development and regulatory services. IntelGenx state-of-the art manufacturing facility, established for the VersaFilmTM technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. IntelGenx Technologies Corp. is listed on the TSX-V and OTC-QX, More information is available about the company at:

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.